Immunotherapy

Immunotherapy

Immunotherapy Indications

The FDA has approved the use of immunotherapy (immune check point inhibitors) based on specific genetic biomarkers irrespective of the type of cancer or organ of origin eg.MSI-High tumors.

Precision oncology has revolutionized cancer therapy. Identifying cancers that might benefit from immunotherapy is possible through the genetic analysis of the tumors.

Call Appointment